Actionable Advice and Resources for Knocking Down Obstacles to Trial Participation

Published on

Topics include: Understanding

Downloadable Program Guide (PDF)

More often than not, only a small fraction of patients enroll in a trial due to barriersposed by financial logistics, distrust and travel, to name a few. How do we remove obstacles, clearing the way for patients to have more access to clinical trials? How can both doctors and patients work together to drive research forward? In this Clinical Trial MythBusters program, Lazarex Chairman Dana Dornsife and four-time clinical trial participant and multiple myeloma survivor Reina Weiner examines the barriers to enrollment, evaluates patient needs and shares resources to help guide people through the clinical trial process.

This is a Patient Empowerment Network program produced by Patient Power. We thank AbbVie, Inc., Astellas, Celgene Corporation, and Novartis for their support.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

View more programs featuring , and

Produced in association with

Related Programs

Precision Medicine: Can Biomarkers Help Patients Find a Good Fit for Clinical Trials?

A panel of experts discuss how precision medicine may influence trial eligibility, cost of treatment, pace of drug development and more. Can biomarkers make the clinical trial process more efficient? Watch now to find out.

Published:

Sugar Pill Myth: What Am I Really Getting in a Clinical Trial?

One barrier to clinical trial enrollment is the myth that patients might receive a sugar pill and get no treatment at all. Watch as Dr. Heather Wakelee lays out the clinical trial facts.

Published:

Clinical Trial MythBusters: Are Clinical Trials a Gamble for Me or My Loved One?

Dr. Liza Villaruz, Sheila Hoff and patient, Dr. Michael Weitz discuss whether clinical trials are a gamble and whether the risks outweigh the benefits for patients and their care partners.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on December 6, 2018